Skip to main content
Log in

ASO Visual Abstract: The Role of Adjuvant Use of the PlasmaJet® Device During Cytoreductive Surgery for Advanced-Stage Ovarian Cancer—Results of the PlaComOv-Study, a Randomized, Controlled Trial in the Netherlands

  • ASO Visual Abstract
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to G. M. Nieuwenhuyzen-de Boer MD.

Ethics declarations

Disclosure

Ingrid A. Boere—translational research (ctDNA) to the employer (Erasmus MC Cancer Institute) grant by GSK. Nieuwenhuyzen-de Boer—Grant from ZonMw received for the project. No relevant conflicts of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Nieuwenhuyzen-de Boer, G.M., Hofhuis, W., Reesink-Peters, N. et al. ASO Visual Abstract: The Role of Adjuvant Use of the PlasmaJet® Device During Cytoreductive Surgery for Advanced-Stage Ovarian Cancer—Results of the PlaComOv-Study, a Randomized, Controlled Trial in the Netherlands. Ann Surg Oncol 29, 4846–4847 (2022). https://doi.org/10.1245/s10434-022-11820-w

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-022-11820-w

Navigation